89: The effect of concomitant hysterectomy on complications following pelvic organ prolapse surgery

Abstract

was performed to identify predictors of readmission in those with a VTE. RESULTS: The results demonstrated that the overall rate of VTE was 0.5% (375/75,134) for benign and 1.84% (271/14,690) for malignant indications. Ovarian cancer patients had the highest rates of VTE 3% (131/4,242). Readmission rates in those with a VTE were similar for benign and malignant cases at 30 days (5.9% vs. 5.4%, p1⁄40.8) and 90-days (18.9% vs. 20.3%, p1⁄40.66). On regression analysis, significant predictors of readmission included robotic radical hysterectomy (OR 9.1, 95% CI 1.3 -63) and surgery at a teaching hospital (OR 0.29, 95% CI 0.12-0.71). Trend analysis revealed non-significant variation in the yearly rates of VTE with a slight increase in endometrial cancer patients from 2012 to 2013 (1.15% to 1.54%) and decrease in ovarian cancer VTE rates declining from 3.6% to 3% (p > 0.05) (Figure 1). CONCLUSION: VTE rate in the same hospitalization as the index surgery has remained stable for all indications of hysterectomy from 2012 to 2015. Current preventative strategies might have plateaued in their efficacy, and newer approaches to further reduce the risk of VTE should be investigated. For those experiencing a VTE, one in five patients were readmitted within 90 days indicating more resources should be allocated to this patient population to prevent readmission.